← Back to Search

Other

surgical stabilization for Multiple Rib Fractures (SSRF Trial)

N/A
Waitlist Available
Led By David E Meyer, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Blunt trauma mechanism
Radiographic flail segment (defined as greater than 2 fractures in greater than 3 consecutive ribs) or greater than 5 consecutive rib fractures or greater than 1 rib fractures with bicortical displacement
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hospital discharge (about 20 to 30 days)
Awards & highlights

SSRF Trial Summary

This trial will compare the outcomes of two different treatments for adults with rib fractures. One group will receive usual care, while the other group will receive usual care plus early surgical stabilization. The trial will also evaluate how different subgroups of patients respond to the two treatments and what effect multiple rib fractures have on patients' post-discharge health and ability to return to work or usual physical activity.

Eligible Conditions
  • Multiple Rib Fractures
  • Traumatic Chest Injury

SSRF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SSRF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hospital discharge (about 20 to 30 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and hospital discharge (about 20 to 30 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Length of Stay
Secondary outcome measures
Health Status as Assessed by Index Score on the Euroqol-5D-5L
Health Status as Assessed by Visual Analog Scale (VAS) Score on the Euro Quality of Life Questionnaire (Euro QoL 5-D 5-L)
Health Status as Indicated by Level of Impairment as Assessed by the Euroqol-5D-5L
+15 more

SSRF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Early surgical stabilizationExperimental Treatment1 Intervention
This arm will include early surgical stabilization (within 72 hours of admission) in addition to the usual care received for patients with multiple rib fractures. Usual care will involve pain management.
Group II: Usual careActive Control1 Intervention
This arm will be usual care only. Usual care will include pain managment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
surgical stabilization
2020
N/A
~90

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
316 Previous Clinical Trials
390,569 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
902 Previous Clinical Trials
321,037 Total Patients Enrolled
National Center for Advancing Translational Science (NCATS)NIH
99 Previous Clinical Trials
36,290 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current opportunities to participate in this experiment?

"Affirmative. Clinicaltrials.gov displays that this trial is recruiting for 150 individuals at one centre, and was initially listed on February 23rd 2020 before being revised March 21st 2022."

Answered by AI

How many participants have been admitted to the experiment thus far?

"Affirmative. Clinicaltrials.gov lists this medical trial as currently recruiting patients, with the original post date of February 23rd 2020 and last updated on March 21st 2022. The study is seeking to enroll 150 participants at one primary site."

Answered by AI
~17 spots leftby Mar 2025